Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation

Ischemic stroke is the most widespread cause of disability and a leading cause of death in developed countries. To date, the most potent approved treatment for acute stroke is recanalization therapy with thrombolytic drugs such as tissue plasminogen activator (rt-PA or tPA) or endovascular mechanica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyden, Patrick D., Pryor, Kent E., Minigh, Jennifer, Davis, Thomas P., Griffin, John H., Levy, Howard, Zlokovic, Berislav V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005555/
https://www.ncbi.nlm.nih.gov/pubmed/33790846
http://dx.doi.org/10.3389/fneur.2021.593582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005555/
https://www.ncbi.nlm.nih.gov/pubmed/33790846
http://dx.doi.org/10.3389/fneur.2021.593582

Ejemplares similares